Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015, Article ID 104794, 8 pages
http://dx.doi.org/10.1155/2015/104794
Clinical Study

Staging of Primary Abdominal Lymphomas: Comparison of Whole-Body MRI with Diffusion-Weighted Imaging and 18F-FDG-PET/CT

1Radiology Department, “Maggiore della Carità” University Hospital, University of Eastern Piedmont, Corso Mazzini 18, 28100 Novara, Italy
2Oncohaematology Department, Sant’Andrea Hospital, Corso Mario Abbiate 21, 13100 Vercelli, Italy
3Nuclear Medicine Department, “Maggiore della Carità” University Hospital, University of Eastern Piedmont, Corso Mazzini 18, 28100 Novara, Italy

Received 18 May 2015; Revised 22 August 2015; Accepted 23 August 2015

Academic Editor: Tatsuya Toyokawa

Copyright © 2015 Alessandro Stecco et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Freeman, J. W. Berg, and S. J. Cutler, “Occurrence and prognosis of extranodal lymphomas,” Cancer, vol. 29, no. 1, pp. 252–260, 1972. View at Google Scholar · View at Scopus
  2. I. M. Dawson, J. S. Cornes, and B. C. Morson, “Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis,” British Journal of Surgery, vol. 49, no. 213, pp. 80–89, 1961. View at Publisher · View at Google Scholar
  3. K. J. Lewin, M. Ranchod, and R. F. Dorfman, “Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease,” Cancer, vol. 42, no. 2, pp. 693–707, 1978. View at Google Scholar · View at Scopus
  4. R. Herrmann, A. M. Panahon, M. P. Barcos, D. Walsh, and L. Stutzman, “Gastrointestinal involvement in non-Hodgkin's lymphoma,” Cancer, vol. 46, no. 1, pp. 215–222, 1980. View at Publisher · View at Google Scholar · View at Scopus
  5. M. A. Rizvi, A. M. Evens, M. S. Tallman, B. P. Nelson, and S. T. Rosen, “T-cell non-Hodgkin lymphoma,” Blood, vol. 107, no. 4, pp. 1255–1264, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. S. M. Ansell and J. Armitage, “Non-Hodgkin lymphoma: diagnosis and treatment,” Mayo Clinic Proceedings, vol. 80, no. 8, pp. 1087–1097, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Musshoff, “Clinical staging classification of non Hodgkin's lymphomas,” Strahlentherapie, vol. 153, no. 4, pp. 218–221, 1977. View at Google Scholar · View at Scopus
  8. A. Ruskoné-Fourmestroux, B. Drogosics, A. Morgner, A. Wotherspoon, and D. De Jong, “Paris staging system for primary gastrointestinal lymphomas,” Gut, vol. 52, no. 6, pp. 912–913, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Antoch, F. M. Vogt, L. S. Freudenberg et al., “Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology,” The Journal of the American Medical Association, vol. 290, no. 24, pp. 3199–3206, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Ghimire, G.-Y. Wu, and L. Zhu, “Primary gastrointestinal lymphoma,” World Journal of Gastroenterology, vol. 17, no. 6, pp. 697–707, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Di Raimondo, L. Caruso, G. Bonanno et al., “Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma?” Annals of Oncology, vol. 18, no. 2, pp. 351–356, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. A. R. Padhani, D.-M. Koh, and D. J. Collins, “Whole-body diffusion-weighted MR imaging in cancer: current status and research directions,” Radiology, vol. 261, no. 3, pp. 700–718, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Lin, A. Luciani, E. Itti et al., “Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma,” European Radiology, vol. 20, no. 8, pp. 2027–2038, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. M. E. Mayerhoefer, G. Karanikas, K. Kletter et al., “Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients,” Clinical Cancer Research, vol. 20, no. 11, pp. 2984–2993, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Takahara, Y. Imai, T. Yamashita, S. Yasuda, S. Nasu, and M. Van Cauteren, “Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display,” Radiation Medicine, vol. 4, no. 22, pp. 275–282, 2004. View at Google Scholar
  16. J. Gu, T. Chan, J. Zhang, A. Y. H. Leung, Y.-L. Kwong, and P.-L. Khong, “Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma,” American Journal of Roentgenology, vol. 197, no. 3, pp. W384–W391, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Abdulqadhr, D. Molin, G. Åström et al., “Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients,” Acta Radiologica, vol. 52, no. 2, pp. 173–180, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. D.-M. Koh and D. J. Collins, “Diffusion-weighted MRI in the body: applications and challenges in oncology,” American Journal of Roentgenology, vol. 188, no. 6, pp. 1622–1635, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Lin, E. Itti, A. Luciani, C. Haioun, M. Meignan, and A. Rahmouni, “Whole-body diffusion-weighted imaging in lymphoma,” Cancer Imaging, vol. 10, pp. S172–S178, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. C. J. Kellenberger, S. F. Miller, M. Khan, D. L. Gilday, S. Weitzman, and P. S. Babyn, “Initial experience with FSE STIR whole-body MR imaging for staging lymphoma in children,” European Radiology, vol. 14, no. 10, pp. 1829–1841, 2004. View at Publisher · View at Google Scholar
  21. T. C. Kwee, T. Takahara, P. R. Luijten, and R. A. J. Nievelstein, “ADC measurements of lymph nodes: inter- and intra-observer reproducibility study and an overview of the literature,” European Journal of Radiology, vol. 75, no. 2, pp. 215–220, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. E. E. Pakos, A. D. Fotopoulos, and J. P. A. Ioannidis, “18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis,” Journal of Nuclear Medicine, vol. 46, no. 6, pp. 958–963, 2005. View at Google Scholar · View at Scopus
  23. B. D. Cheson, S. J. Horning, B. Coiffer et al., “Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI sponsored international working group,” Clinical Oncology, vol. 17, p. 1244, 1999. View at Google Scholar
  24. P. Seam, M. E. Juweid, and B. D. Cheson, “The role of FDG-PET scans in patients with lymphoma,” Blood, vol. 110, no. 10, pp. 3507–3516, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Perry, Y. Herishanu, U. Metzer et al., “Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma,” European Journal of Haematology, vol. 79, no. 3, pp. 205–209, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. D. J. Brenner and C. D. Elliston, “Estimated radiation on risks potentially associated with full-body CT screening,” Radiology, vol. 232, no. 3, pp. 735–738, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Huang, M. W.-M. Law, and P.-L. Khong, “Whole-body PET/CT scanning: estimation of radiation dose and cancer risk,” Radiology, vol. 251, no. 1, pp. 166–174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Plathow, M. Walz, M. P. Lichy et al., “Cost considerations for whole-body MRI and PET/CT as part of oncologic staging,” Der Radiologe, vol. 48, no. 4, pp. 384–396, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. A. C. Wotherspoon, C. Doglioni, and P. G. Isaacson, “Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT): a multifocal disease,” Histopathology, vol. 20, no. 1, pp. 29–34, 1992. View at Publisher · View at Google Scholar · View at Scopus
  30. S. M. Cohen, M. Petryk, M. Varma, P. S. Kozuch, E. D. Ames, and M. L. Grossbard, “Non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue,” Oncologist, vol. 11, no. 10, pp. 1100–1117, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. A. J. A. Deutsch, A. Aigelsreiter, P. B. Staber et al., “MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation,” Blood, vol. 109, no. 8, pp. 3500–3504, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Boot, “Diagnosis and staging in gastrointestinal lymphoma,” Best Practice and Research: Clinical Gastroenterology, vol. 24, no. 1, pp. 3–12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. B. D. Cheson, B. Pfistner, M. E. Juweid et al., “Revised response criteria for malignant lymphoma,” Journal of Clinical Oncology, vol. 25, no. 5, pp. 579–586, 2007. View at Publisher · View at Google Scholar · View at Scopus